8. Atrion (ATRI - Get Report) makes ophthalmology, cardiovascular and fluid-delivery products for health-care markets. Third-quarter profit increased 21% to $5.4 million, or $2.66 a share, as revenue stretched 7.8% to $27 million. The operating margin rose from 26% to 29%. Atrion's balance sheet stores $17 million of cash, equal to a quick ratio of 2.2, and no debt. Its stock trades at a forward earnings multiple of 15, a book value multiple of 2.8, a sales multiple of 3.1 and a cash flow multiple of 11, 24%, 35%, 15% and 20% discounts to health care peer averages.
Expected Return: The model forecasts that Atrion's stock will appreciate 15% to $189.39.